← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Clinical Data Interchange Stand/Consort
Austin, TX
$3,362,982
Total funding
9
Grants
Funding over time
peak $749.7K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$3,362,982 · 9
By mechanism
U24$2,803,446 · 7
U01$411,536 · 1
R24$148,000 · 1
Investigators at Clinical Data Interchange Stand/Consort
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development.$249,996
U24 · FY2018 · FD
Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development.$249,996
U24 · FY2018 · FD
An eSubmission pilot with stakeholder education to ensure successful adoption of data standards by regulators, industry, and global organizations for tobacco research, regulatory review, data sharing.$249,922
U24 · FY2024 · FD
An eSubmission pilot with stakeholder education to ensure successful adoption of data standards by regulators, industry, and global organizations for tobacco research, regulatory review, data sharing.$249,764
U24 · FY2025 · FD
Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development.$249,725
U24 · FY2018 · FD
Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making.$231,409
U24 · FY2023 · FD
Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making.$230,834
U24 · FY2022 · FD
Development of a CDISC Therapeutic Area Standard for Lung Cancer$224,971
U01 · FY2016 · FD
Development of CDISC Therapeutic Area Standard for Colorectal Cancer$223,593
U24 · FY2015 · FD
Development of Prostate Cancer Standards$220,742
U24 · FY2014 · FD
Development of a CDISC Therapeutic Area Standard for Lung Cancer$186,565
U01 · FY2017 · FD
Leveraging CDISC innovative approaches and emerging technology to expedite development of open, end-to-end tobacco standards to facilitate regulatory submission, review and decision making.$182,837
U24 · FY2023 · FD
Advancing Regulatory Science through Novel Terminology and Standards Development$148,000
R24 · FY2011 · FD
Development of Prostate Cancer Standards$115,597
U24 · FY2015 · FD
Developing Acute Kidney Injury CDISC Clinical Data Standards for Clinical Research and Drug Development.$99,921
U24 · FY2019 · FD
Developing Congestive Heart Failure CDISC Clinical Data Standards for Clinical Research and Drug Development.$99,555
U24 · FY2019 · FD
Developing Psoriasis CDISC Clinical Data Standards for Clinical Research and Drug Development.$99,555
U24 · FY2019 · FD
Development of CDISC Therapeutic Area Standard for Colorectal Cancer$50,000
U24 · FY2017 · FD